Manipal Health Enterprises Ltd
Incorporated in 2010, Manipal Health
Enterprises Limited is a healthcare
service providers, operating a large
network of multi-specialty hospitals,
clinics, and diagnostic centres across
the country.[1]
- Market Cap ₹ 86,835 Cr.
- Current Price ₹ 660
- High / Low ₹ 676 / 635
- Stock P/E 95.8
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 12.1 %
- ROE 12.7 %
- Face Value ₹ 2.00
Pros
- Company has delivered good profit growth of 76.8% CAGR over last 5 years
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 1,813 | 3,975 | 4,806 | 6,172 | 8,242 | 10,336 | |
| 1,483 | 3,054 | 3,527 | 4,489 | 6,115 | 7,725 | |
| Operating Profit | 330 | 921 | 1,279 | 1,683 | 2,127 | 2,611 |
| OPM % | 18% | 23% | 27% | 27% | 26% | 25% |
| -47 | 293 | -48 | -86 | 134 | 111 | |
| Interest | 205 | 326 | 329 | 455 | 512 | 864 |
| Depreciation | 183 | 256 | 315 | 397 | 507 | 680 |
| Profit before tax | -105 | 632 | 586 | 745 | 1,242 | 1,178 |
| Tax % | 30% | 14% | 27% | 28% | 13% | 22% |
| -138 | 542 | 429 | 533 | 1,082 | 917 | |
| EPS in Rs | -20.12 | 71.63 | 56.73 | 70.50 | 27.65 | 7.56 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 42% |
| 3 Years: | 29% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 77% |
| 3 Years: | 22% |
| TTM: | -10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 16% |
| Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 69 | 76 | 76 | 76 | 77 | 236 |
| Reserves | 1,064 | 2,732 | 3,166 | 3,940 | 5,770 | 8,190 |
| 1,575 | 2,017 | 2,184 | 5,130 | 6,385 | 12,863 | |
| 1,316 | 2,521 | 2,337 | 1,612 | 1,658 | 3,446 | |
| Total Liabilities | 4,024 | 7,346 | 7,763 | 10,757 | 13,890 | 24,735 |
| 2,278 | 4,582 | 4,784 | 6,934 | 9,826 | 18,753 | |
| CWIP | 412 | 1,089 | 1,033 | 1,266 | 614 | 795 |
| Investments | 551 | 768 | 1,038 | 1,121 | 1,776 | 2,675 |
| 784 | 907 | 908 | 1,436 | 1,675 | 2,511 | |
| Total Assets | 4,024 | 7,346 | 7,763 | 10,757 | 13,890 | 24,735 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 426 | 805 | 1,149 | 1,389 | 1,570 | 2,078 | |
| -188 | -1,711 | -994 | -870 | -2,544 | -7,025 | |
| -280 | 941 | -144 | -250 | 904 | 4,954 | |
| Net Cash Flow | -42 | 34 | 12 | 268 | -70 | 8 |
| Free Cash Flow | 334 | 629 | 823 | 1,394 | 520 | 767 |
| CFO/OP | 106% | 98% | 105% | 100% | 87% | 96% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 26 | 27 | 24 | 27 | 28 | 33 |
| Inventory Days | 20 | 28 | 23 | 30 | 29 | 29 |
| Days Payable | 371 | 246 | 283 | 330 | 245 | 253 |
| Cash Conversion Cycle | -325 | -190 | -236 | -273 | -188 | -190 |
| Working Capital Days | -95 | -113 | -56 | -59 | -40 | -70 |
| ROCE % | 18% | 19% | 19% | 16% | 12% |
Documents
Announcements
-
Intimation Under Regulation 30 (5) Of The SEBI (LODR Regulations) 2015
7h - Board authorizes KMPs to determine materiality and disclose events under Regulation 30(5).
-
Intimation Under Regulation 7(1) Of The SEBI (LODR Regulations) 2015
13h - Manipal Health confirms KFin Technologies continues as RTA from February 13, 2025.
-
Intimation Under Regulation 6(1) Of The SEBI (LODR) Regulations 2015
13h - Manipal Health confirms Sathish K R continues as Compliance Officer from November 25, 2025.
-
Intimation Under Regulation 8(2) Of The Securities Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015
13h - Manipal Health submits fair disclosure code under SEBI PIT Regulations.
-
Closure of Trading Window
14h - Trading window closed from August 5, 2026 until 48 hours after Q1 FY26 results.
Business Profile:[1][2]
Manipal Health Enterprises is one of India's largest private multispecialty hospital chains, providing healthcare services across the entire continuum of care, from outpatient consultations and diagnostics to tertiary and quaternary care, organ transplantation, robotic surgery and complex interventions.